APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio Implant Allograft & Xenograft

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bio Implant Allograft & Xenograft Market Analysis and Forecast 2026-2032

31 December 2025194 pages

Choose your research edition.

Industry ResearchBio Implant Allograft & Xenograft Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio Implant Allograft & Xenograft Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Bio Implant Allograft & Xenograft Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio Implant Allograft & Xenograft Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio Implant Allograft & Xenograft Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Bio Implant Allograft & Xenograft market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bio Implant Allograft & Xenograft is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bio Implant Allograft & Xenograft is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bio Implant Allograft & Xenograft is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bio Implant Allograft & Xenograft is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bio Implant Allograft & Xenograft include Medtronic, Zimmer Biomet, Xtant Medical, Wright Medical, Straumann, OneGraft® Gmbh, Geistlich, DePuy and Collagen Matrix, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bio Implant Allograft & Xenograft, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bio Implant Allograft & Xenograft, also provides the revenue of main regions and countries. Of the upcoming market potential for Bio Implant Allograft & Xenograft, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bio Implant Allograft & Xenograft revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bio Implant Allograft & Xenograft market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bio Implant Allograft & Xenograft revenue, projected growth trends, production technology, application and end-user industry.

Bio Implant Allograft & Xenograft Segment by Company

Medtronic

Zimmer Biomet

Xtant Medical

Wright Medical

Straumann

OneGraft® Gmbh

Geistlich

DePuy

Collagen Matrix

Citagenix Inc

Arthrex

Bio Implant Allograft & Xenograft Segment by Type

Allografts

Xenografts

Bio Implant Allograft & Xenograft Segment by Application

Spinal Fusion

Bone Trauma

Others

Bio Implant Allograft & Xenograft Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio Implant Allograft & Xenograft market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio Implant Allograft & Xenograft and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio Implant Allograft & Xenograft.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bio Implant Allograft & Xenograft in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bio Implant Allograft & Xenograft company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio Implant Allograft & Xenograft revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bio Implant Allograft & Xenograft Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Allografts Major Player Table 3. Xenografts Major Player Table 4. Global Bio Implant Allograft & Xenograft Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Spinal Fusion Major Player Table 6. Bone Trauma Major Player Table 7. Others Major Player Table 8. Bio Implant Allograft & Xenograft Industry Trends Table 9. Bio Implant Allograft & Xenograft Industry Drivers Table 10. Bio Implant Allograft & Xenograft Industry Opportunities and Challenges Table 11. Bio Implant Allograft & Xenograft Industry Restraints Table 12. Global Bio Implant Allograft & Xenograft Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Bio Implant Allograft & Xenograft Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Bio Implant Allograft & Xenograft Market Share by Region (2021-2026) Table 15. Global Bio Implant Allograft & Xenograft Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Bio Implant Allograft & Xenograft Market Share by Region (2027-2032) Table 17. Global Bio Implant Allograft & Xenograft Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Bio Implant Allograft & Xenograft Revenue Market Share by Players (2021-2026) Table 19. Global Bio Implant Allograft & Xenograft Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Bio Implant Allograft & Xenograft Key Players Headquarters & Area Served Table 21. Global Bio Implant Allograft & Xenograft Players, Product Type & Application Table 22. Global Bio Implant Allograft & Xenograft Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Bio Implant Allograft & Xenograft by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Bio Implant Allograft & Xenograft Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bio Implant Allograft & Xenograft Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Bio Implant Allograft & Xenograft Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Bio Implant Allograft & Xenograft Revenue Market Share by Type (2021-2026) Table 29. Global Bio Implant Allograft & Xenograft Revenue Market Share by Type (2027-2032) Table 30. Global Bio Implant Allograft & Xenograft Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Bio Implant Allograft & Xenograft Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Bio Implant Allograft & Xenograft Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Bio Implant Allograft & Xenograft Revenue Market Share by Application (2021-2026) Table 34. Global Bio Implant Allograft & Xenograft Revenue Market Share by Application (2027-2032) Table 35. Medtronic Company Information Table 36. Medtronic Business Overview Table 37. Medtronic Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Medtronic Bio Implant Allograft & Xenograft Product Portfolio Table 39. Medtronic Recent Development Table 40. Zimmer Biomet Company Information Table 41. Zimmer Biomet Business Overview Table 42. Zimmer Biomet Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Zimmer Biomet Bio Implant Allograft & Xenograft Product Portfolio Table 44. Zimmer Biomet Recent Development Table 45. Xtant Medical Company Information Table 46. Xtant Medical Business Overview Table 47. Xtant Medical Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Xtant Medical Bio Implant Allograft & Xenograft Product Portfolio Table 49. Xtant Medical Recent Development Table 50. Wright Medical Company Information Table 51. Wright Medical Business Overview Table 52. Wright Medical Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Wright Medical Bio Implant Allograft & Xenograft Product Portfolio Table 54. Wright Medical Recent Development Table 55. Straumann Company Information Table 56. Straumann Business Overview Table 57. Straumann Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Straumann Bio Implant Allograft & Xenograft Product Portfolio Table 59. Straumann Recent Development Table 60. OneGraft® Gmbh Company Information Table 61. OneGraft® Gmbh Business Overview Table 62. OneGraft® Gmbh Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. OneGraft® Gmbh Bio Implant Allograft & Xenograft Product Portfolio Table 64. OneGraft® Gmbh Recent Development Table 65. Geistlich Company Information Table 66. Geistlich Business Overview Table 67. Geistlich Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Geistlich Bio Implant Allograft & Xenograft Product Portfolio Table 69. Geistlich Recent Development Table 70. DePuy Company Information Table 71. DePuy Business Overview Table 72. DePuy Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. DePuy Bio Implant Allograft & Xenograft Product Portfolio Table 74. DePuy Recent Development Table 75. Collagen Matrix Company Information Table 76. Collagen Matrix Business Overview Table 77. Collagen Matrix Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Collagen Matrix Bio Implant Allograft & Xenograft Product Portfolio Table 79. Collagen Matrix Recent Development Table 80. Citagenix Inc Company Information Table 81. Citagenix Inc Business Overview Table 82. Citagenix Inc Bio Implant Allograft & Xenograft Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Citagenix Inc Bio Implant Allograft & Xenograft Product Portfolio Table 84. Citagenix Inc Recent Development Table 85. Arthrex Company Information Table 86. Arthrex Business Overview Table 87. Arthrex Bio Implant Allograft & Xenograft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Arthrex Bio Implant Allograft & Xenograft Product Portfolio Table 89. Arthrex Recent Development Table 90. North America Bio Implant Allograft & Xenograft Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Bio Implant Allograft & Xenograft Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Bio Implant Allograft & Xenograft Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Bio Implant Allograft & Xenograft Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Bio Implant Allograft & Xenograft Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Bio Implant Allograft & Xenograft Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Bio Implant Allograft & Xenograft Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Bio Implant Allograft & Xenograft Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Bio Implant Allograft & Xenograft Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Bio Implant Allograft & Xenograft Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Bio Implant Allograft & Xenograft Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Bio Implant Allograft & Xenograft Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Bio Implant Allograft & Xenograft Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Bio Implant Allograft & Xenograft Revenue by Country (US$ Million) & (2027-2032) Table 104. China Bio Implant Allograft & Xenograft Revenue by Type (2021-2026) & (US$ Million) Table 105. China Bio Implant Allograft & Xenograft Revenue by Type (2027-2032) & (US$ Million) Table 106. China Bio Implant Allograft & Xenograft Revenue by Application (2021-2026) & (US$ Million) Table 107. China Bio Implant Allograft & Xenograft Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Bio Implant Allograft & Xenograft Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Bio Implant Allograft & Xenograft Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Bio Implant Allograft & Xenograft Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Bio Implant Allograft & Xenograft Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Bio Implant Allograft & Xenograft Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Bio Implant Allograft & Xenograft Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Bio Implant Allograft & Xenograft Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Bio Implant Allograft & Xenograft Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Bio Implant Allograft & Xenograft Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Bio Implant Allograft & Xenograft Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Bio Implant Allograft & Xenograft Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Bio Implant Allograft & Xenograft Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Bio Implant Allograft & Xenograft Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Bio Implant Allograft & Xenograft Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Bio Implant Allograft & Xenograft Image Figure 2. Global Bio Implant Allograft & Xenograft Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio Implant Allograft & Xenograft Market Size Share 2021 VS 2025 VS 2032 Figure 4. Allografts Image Figure 5. Xenografts Image Figure 6. Global Bio Implant Allograft & Xenograft Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bio Implant Allograft & Xenograft Market Size Share 2021 VS 2025 VS 2032 Figure 8. Spinal Fusion Image Figure 9. Bone Trauma Image Figure 10. Others Image Figure 11. Global Bio Implant Allograft & Xenograft Market Size (US$ Million) & (2021-2032) Figure 12. Global Bio Implant Allograft & Xenograft Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Bio Implant Allograft & Xenograft Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Bio Implant Allograft & Xenograft Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Bio Implant Allograft & Xenograft Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Bio Implant Allograft & Xenograft Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Bio Implant Allograft & Xenograft Revenue Market Share by Type (2021-2032) Figure 19. Global Bio Implant Allograft & Xenograft Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Bio Implant Allograft & Xenograft Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Bio Implant Allograft & Xenograft Revenue Market Share by Application (2021-2032) Figure 22. North America Bio Implant Allograft & Xenograft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032) Figure 24. North America Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032) Figure 25. North America Bio Implant Allograft & Xenograft Revenue Share by Country (2021-2032) Figure 26. United States Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Bio Implant Allograft & Xenograft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032) Figure 31. Europe Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032) Figure 32. Europe Bio Implant Allograft & Xenograft Revenue Share by Country (2021-2032) Figure 33. Germany Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Bio Implant Allograft & Xenograft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032) Figure 43. China Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032) Figure 44. Asia Bio Implant Allograft & Xenograft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032) Figure 46. Asia Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032) Figure 47. Asia Bio Implant Allograft & Xenograft Revenue Share by Region (2021-2032) Figure 48. Japan Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Bio Implant Allograft & Xenograft Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032) Figure 56. SAMEA Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032) Figure 57. SAMEA Bio Implant Allograft & Xenograft Revenue Share by Country (2021-2032) Figure 58. Brazil Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Bio Implant Allograft & Xenograft Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Allografts
  • Xenografts
Applications
  • Spinal Fusion
  • Bone Trauma
  • Others
Companies covered
  • Medtronic
  • Zimmer Biomet
  • Xtant Medical
  • Wright Medical
  • Straumann
  • OneGraft® Gmbh
  • Geistlich
  • DePuy
  • Collagen Matrix
  • Citagenix Inc
  • Arthrex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bio Implant Allograft & Xenograft Market by Type
  3. 1.2.1 Global Bio Implant Allograft & Xenograft Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Allografts
  5. 1.2.3 Xenografts
  6. 1.3 Bio Implant Allograft & Xenograft Market by Application
  7. 1.3.1 Global Bio Implant Allograft & Xenograft Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Spinal Fusion
  9. 1.3.3 Bone Trauma
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Bio Implant Allograft & Xenograft Market Dynamics
  1. 2.1 Bio Implant Allograft & Xenograft Industry Trends
  2. 2.2 Bio Implant Allograft & Xenograft Industry Drivers
  3. 2.3 Bio Implant Allograft & Xenograft Industry Opportunities and Challenges
  4. 2.4 Bio Implant Allograft & Xenograft Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bio Implant Allograft & Xenograft Market Perspective (2021-2032)
  2. 3.2 Global Bio Implant Allograft & Xenograft Growth Trends by Region
  3. 3.2.1 Global Bio Implant Allograft & Xenograft Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bio Implant Allograft & Xenograft Market Size by Region (2021-2026)
  5. 3.2.3 Global Bio Implant Allograft & Xenograft Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bio Implant Allograft & Xenograft Revenue by Players
  2. 4.1.1 Global Bio Implant Allograft & Xenograft Revenue by Players (2021-2026)
  3. 4.1.2 Global Bio Implant Allograft & Xenograft Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bio Implant Allograft & Xenograft Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bio Implant Allograft & Xenograft Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bio Implant Allograft & Xenograft Key Players Headquarters & Area Served
  7. 4.4 Global Bio Implant Allograft & Xenograft Players, Product Type & Application
  8. 4.5 Global Bio Implant Allograft & Xenograft Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bio Implant Allograft & Xenograft Market CR5 and HHI
  11. 4.6.3 2025 Bio Implant Allograft & Xenograft Tier 1, Tier 2, and Tier 3
5 Bio Implant Allograft & Xenograft Market Size by Type
  1. 5.1 Global Bio Implant Allograft & Xenograft Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bio Implant Allograft & Xenograft Revenue by Type (2021-2032)
  3. 5.3 Global Bio Implant Allograft & Xenograft Revenue Market Share by Type (2021-2032)
6 Bio Implant Allograft & Xenograft Market Size by Application
  1. 6.1 Global Bio Implant Allograft & Xenograft Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bio Implant Allograft & Xenograft Revenue by Application (2021-2032)
  3. 6.3 Global Bio Implant Allograft & Xenograft Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Bio Implant Allograft & Xenograft Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 Zimmer Biomet
  8. 7.2.1 Zimmer Biomet Company Information
  9. 7.2.2 Zimmer Biomet Business Overview
  10. 7.2.3 Zimmer Biomet Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zimmer Biomet Bio Implant Allograft & Xenograft Product Portfolio
  12. 7.2.5 Zimmer Biomet Recent Developments
  13. 7.3 Xtant Medical
  14. 7.3.1 Xtant Medical Company Information
  15. 7.3.2 Xtant Medical Business Overview
  16. 7.3.3 Xtant Medical Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Xtant Medical Bio Implant Allograft & Xenograft Product Portfolio
  18. 7.3.5 Xtant Medical Recent Developments
  19. 7.4 Wright Medical
  20. 7.4.1 Wright Medical Company Information
  21. 7.4.2 Wright Medical Business Overview
  22. 7.4.3 Wright Medical Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Wright Medical Bio Implant Allograft & Xenograft Product Portfolio
  24. 7.4.5 Wright Medical Recent Developments
  25. 7.5 Straumann
  26. 7.5.1 Straumann Company Information
  27. 7.5.2 Straumann Business Overview
  28. 7.5.3 Straumann Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Straumann Bio Implant Allograft & Xenograft Product Portfolio
  30. 7.5.5 Straumann Recent Developments
  31. 7.6 OneGraft® Gmbh
  32. 7.6.1 OneGraft® Gmbh Company Information
  33. 7.6.2 OneGraft® Gmbh Business Overview
  34. 7.6.3 OneGraft® Gmbh Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  35. 7.6.4 OneGraft® Gmbh Bio Implant Allograft & Xenograft Product Portfolio
  36. 7.6.5 OneGraft® Gmbh Recent Developments
  37. 7.7 Geistlich
  38. 7.7.1 Geistlich Company Information
  39. 7.7.2 Geistlich Business Overview
  40. 7.7.3 Geistlich Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Geistlich Bio Implant Allograft & Xenograft Product Portfolio
  42. 7.7.5 Geistlich Recent Developments
  43. 7.8 DePuy
  44. 7.8.1 DePuy Company Information
  45. 7.8.2 DePuy Business Overview
  46. 7.8.3 DePuy Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  47. 7.8.4 DePuy Bio Implant Allograft & Xenograft Product Portfolio
  48. 7.8.5 DePuy Recent Developments
  49. 7.9 Collagen Matrix
  50. 7.9.1 Collagen Matrix Company Information
  51. 7.9.2 Collagen Matrix Business Overview
  52. 7.9.3 Collagen Matrix Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Collagen Matrix Bio Implant Allograft & Xenograft Product Portfolio
  54. 7.9.5 Collagen Matrix Recent Developments
  55. 7.10 Citagenix Inc
  56. 7.10.1 Citagenix Inc Company Information
  57. 7.10.2 Citagenix Inc Business Overview
  58. 7.10.3 Citagenix Inc Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Citagenix Inc Bio Implant Allograft & Xenograft Product Portfolio
  60. 7.10.5 Citagenix Inc Recent Developments
  61. 7.11 Arthrex
  62. 7.11.1 Arthrex Company Information
  63. 7.11.2 Arthrex Business Overview
  64. 7.11.3 Arthrex Bio Implant Allograft & Xenograft Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Arthrex Bio Implant Allograft & Xenograft Product Portfolio
  66. 7.11.5 Arthrex Recent Developments
8 North America
  1. 8.1 North America Bio Implant Allograft & Xenograft Revenue (2021-2032)
  2. 8.2 North America Bio Implant Allograft & Xenograft Revenue by Type (2021-2032)
  3. 8.2.1 North America Bio Implant Allograft & Xenograft Revenue by Type (2021-2026)
  4. 8.2.2 North America Bio Implant Allograft & Xenograft Revenue by Type (2027-2032)
  5. 8.3 North America Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032)
  6. 8.4 North America Bio Implant Allograft & Xenograft Revenue by Application (2021-2032)
  7. 8.4.1 North America Bio Implant Allograft & Xenograft Revenue by Application (2021-2026)
  8. 8.4.2 North America Bio Implant Allograft & Xenograft Revenue by Application (2027-2032)
  9. 8.5 North America Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032)
  10. 8.6 North America Bio Implant Allograft & Xenograft Revenue by Country
  11. 8.6.1 North America Bio Implant Allograft & Xenograft Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bio Implant Allograft & Xenograft Revenue by Country (2021-2026)
  13. 8.6.3 North America Bio Implant Allograft & Xenograft Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Bio Implant Allograft & Xenograft Revenue (2021-2032)
  2. 9.2 Europe Bio Implant Allograft & Xenograft Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bio Implant Allograft & Xenograft Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bio Implant Allograft & Xenograft Revenue by Type (2027-2032)
  5. 9.3 Europe Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bio Implant Allograft & Xenograft Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bio Implant Allograft & Xenograft Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bio Implant Allograft & Xenograft Revenue by Application (2027-2032)
  9. 9.5 Europe Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bio Implant Allograft & Xenograft Revenue by Country
  11. 9.6.1 Europe Bio Implant Allograft & Xenograft Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bio Implant Allograft & Xenograft Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bio Implant Allograft & Xenograft Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Bio Implant Allograft & Xenograft Revenue (2021-2032)
  2. 10.2 China Bio Implant Allograft & Xenograft Revenue by Type (2021-2032)
  3. 10.2.1 China Bio Implant Allograft & Xenograft Revenue by Type (2021-2026)
  4. 10.2.2 China Bio Implant Allograft & Xenograft Revenue by Type (2027-2032)
  5. 10.3 China Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032)
  6. 10.4 China Bio Implant Allograft & Xenograft Revenue by Application (2021-2032)
  7. 10.4.1 China Bio Implant Allograft & Xenograft Revenue by Application (2021-2026)
  8. 10.4.2 China Bio Implant Allograft & Xenograft Revenue by Application (2027-2032)
  9. 10.5 China Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bio Implant Allograft & Xenograft Revenue (2021-2032)
  2. 11.2 Asia Bio Implant Allograft & Xenograft Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bio Implant Allograft & Xenograft Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bio Implant Allograft & Xenograft Revenue by Type (2027-2032)
  5. 11.3 Asia Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bio Implant Allograft & Xenograft Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bio Implant Allograft & Xenograft Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bio Implant Allograft & Xenograft Revenue by Application (2027-2032)
  9. 11.5 Asia Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bio Implant Allograft & Xenograft Revenue by Country
  11. 11.6.1 Asia Bio Implant Allograft & Xenograft Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bio Implant Allograft & Xenograft Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bio Implant Allograft & Xenograft Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bio Implant Allograft & Xenograft Revenue (2021-2032)
  2. 12.2 SAMEA Bio Implant Allograft & Xenograft Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bio Implant Allograft & Xenograft Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bio Implant Allograft & Xenograft Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bio Implant Allograft & Xenograft Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bio Implant Allograft & Xenograft Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bio Implant Allograft & Xenograft Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bio Implant Allograft & Xenograft Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bio Implant Allograft & Xenograft Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bio Implant Allograft & Xenograft Revenue by Country
  11. 12.6.1 SAMEA Bio Implant Allograft & Xenograft Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bio Implant Allograft & Xenograft Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bio Implant Allograft & Xenograft Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst